BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 9001754)

  • 1. Neuroendocrine tumors of the lung. Pathology and molecular biology.
    Vuitch F; Sekido Y; Fong K; Mackay B; Minna JD; Gazdar AF
    Chest Surg Clin N Am; 1997 Feb; 7(1):21-47. PubMed ID: 9001754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular genetics of small cell lung carcinoma.
    Wistuba II; Gazdar AF; Minna JD
    Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic and molecular aspects of lung cancer.
    Panani AD; Roussos C
    Cancer Lett; 2006 Jul; 239(1):1-9. PubMed ID: 16112428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular pathogenesis of lung cancer and potential translational applications.
    Minna JD; Fong K; Zöchbauer-Müller S; Gazdar AF
    Cancer J; 2002; 8 Suppl 1():S41-6. PubMed ID: 12075701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular and cellular basis of human lung cancer.
    Gazdar AF
    Anticancer Res; 1994; 14(1B):261-7. PubMed ID: 8166465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular genetic characterization of neuroendocrine lung cancer cell lines.
    Lai SL; Brauch H; Knutsen T; Johnson BE; Nau MM; Mitsudomi T; Tsai CM; Whang-Peng J; Zbar B; Kaye FJ
    Anticancer Res; 1995; 15(2):225-32. PubMed ID: 7762988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
    Lerman MI; Minna JD
    Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathology of lung cancer.
    Wistuba II; Gazdar AF
    Verh Dtsch Ges Pathol; 2000; 84():96-105. PubMed ID: 11217455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular profiling of lung carcinoma: identifying clinically useful tumor markers for diagnosis and prognosis.
    Dacic S
    Expert Rev Mol Diagn; 2007 Jan; 7(1):77-86. PubMed ID: 17187486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering.
    Girard L; Zöchbauer-Müller S; Virmani AK; Gazdar AF; Minna JD
    Cancer Res; 2000 Sep; 60(17):4894-906. PubMed ID: 10987304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular biologic features of non-small cell lung cancer. Clinical implications.
    Rusch VW; Dmitrovsky E
    Chest Surg Clin N Am; 1995 Feb; 5(1):39-55. PubMed ID: 7743147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking molecular damage in bronchial epithelium.
    Wistuba II; Mao L; Gazdar AF
    Oncogene; 2002 Oct; 21(48):7298-306. PubMed ID: 12379874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions.
    Tang X; Liu D; Shishodia S; Ozburn N; Behrens C; Lee JJ; Hong WK; Aggarwal BB; Wistuba II
    Cancer; 2006 Dec; 107(11):2637-46. PubMed ID: 17078054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in novel candidate tumor suppressor genes, ING1 and ING2 in human lung cancer.
    Okano T; Gemma A; Hosoya Y; Hosomi Y; Nara M; Kokubo Y; Yoshimura A; Shibuya M; Nagashima M; Harris CC; Kudoh S
    Oncol Rep; 2006 Mar; 15(3):545-9. PubMed ID: 16465410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Biology of small-cell bronchogenic carcinoma: recent advances].
    Levy R; Andrieu JM; Even P
    Bull Cancer; 1992; 79(1):25-46. PubMed ID: 1325850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis and pathology.
    Yesner R
    Clin Chest Med; 1993 Mar; 14(1):17-30. PubMed ID: 8384961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and cellular biology of small cell lung cancer.
    Sattler M; Salgia R
    Semin Oncol; 2003 Feb; 30(1):57-71. PubMed ID: 12635090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
    Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
    Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent progress in the biology of small cell bronchial carcinoma].
    Thomas F; Arriagada R; Le Chevalier T; Poupon MF
    Rev Mal Respir; 1988; 5(5):451-61. PubMed ID: 2847257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.